Also known as Azilect
Rasagiline (Azilect, AGN 1135) is an irreversible inhibitor of monoamine oxidase used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases. It is selective for MAO type B over type A by a factor of fourteen.Source: Wikipedia
Estimated Total Cost: $294.22 for an average of 28 days supply
Patients are most commonly prescribed rasagiline to treat parkinson disease, abnormal involuntary movements, problems with movement, and hypercholesterolemia.